Mabtech
Anna Lundin is a research scientist at Mabtech AB since November 2015, actively contributing to the Hybridoma group in the development of new monoclonal antibodies for ELISA, ELISpot, and Fluorospot applications. Prior to this role, Anna served as a laboratory engineer at AstraZeneca and Karolinska Universitetssjukhuset, focusing on quality assurance and clinical microbiology, respectively. Anna also has experience as a teaching assistant at Uppsala University and worked as an adventure guide from 2001 to 2007. Anna holds a Master of Science in Biology from Uppsala University and studied at The Australian National University.
This person is not in any offices
Mabtech
We are a Swedish biotech company developing immunoassays for life science research. Our goal is to aid research, by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA. To that end, we develop and produce a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. We started off in Stockholm, Sweden in 1986, and our headquarter still lies in Nacka Strand, just east of the inner city. We do everything here, from research and production, to finance, IT, quality control, marketing, distribution, and sales. In addition, we have a sales office in Cincinnati, Ohio, and collaborate with great distributors around the globe. The quality of our products really comes down to our entire organization; the balance between individual action and care for the collective. Because for us, quality isn’t just a word. It’s a mindset, a mantra, and a lens we hold to all our initiatives, whatever the size. Being part of the whole scientific community, we want to do our share in helping science progress. So please see us as peer – feel free to strike up any sort of conversation with us.